• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Suven Life Sciences Ltd Miscellaneous

  • Indian Private
  • BSE Code : 4916.0
  • ISIN : INE495B01038
378.35 6 (1.48%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    367.75

  • Today’s High

    391.00

  • Open

    374.00

  • Perv Close

    372.85

  • 52W Low

    124.11

  • 52W High

    403.35

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    10,690.76

  • Div & Yield %

    0.00

  • Book Value(₹)

    56.51

  • Debt-Equity Ratio

    1.48

  • AGM Date

    03-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    10,690.76

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    28.26

  • BV (₹)

    56.50

  • Sales( ₹ in Cr.)

    7.11

  • NP (in Cr.)

    -64.40

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    -2.10

  • EPS (₹)

    -2.30

  • Traded Value (₹ in Lakhs)

    10,669.57

  • 52 Week High

    403.35

  • 52 Week Low

    124.11

  • Price BSE

    378.0

  • Price NSE

    378.00

  • Market Capital( in Cr.)

    10,669.57

  • P/C Ratio

    -181.70

  • P/E Ratio

    -165.90

  • Price Vs.BV

    -2.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 7.11 6.66 11.69 13.54 11.84 13.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7.11 6.66 11.69 13.54 11.84 13.48
Other Income 13.91 10.73 28.59 14.45 5.32 7.75
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 21.02 17.39 40.28 27.99 17.16 21.23
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.56 0.30 0.26 0.00 0.00 0.00
Employee Cost 24.15 20.82 16.53 15.77 17.46 15.29
Other Manufacturing Expenses 1.62 1.79 1.54 0.93 2.59 0.14
Selling and Administration Expenses 40.17 34.27 23.06 22.95 27.01 27.61
Miscellaneous Expenses 3.52 1.31 1.15 1.52 1.30 0.89
Employee Benefit Expenses 24.15 20.82 16.53 15.77 17.46 15.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 70.02 58.49 42.55 41.18 48.37 43.93
Operating Profit -48.99 -41.11 -2.27 -13.18 -31.22 -22.70
Interest 0.26 0.15 0.24 0.40 0.64 0.91
Gross Profit -49.25 -41.26 -2.51 -13.58 -31.86 -23.61
Depreciation 5.61 5.82 6.50 6.54 4.39 4.35
Profit Before Tax -54.86 -47.08 -9.01 -20.12 -36.25 -27.96
Current Tax 0.00 0.00 -1.00 0.00 0.00 0.38
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 -5.70
Reported Net Profit -54.86 -47.08 -8.01 -20.13 -36.25 -22.63
Extraordinary Items 9.54 4.98 12.01 7.79 3.99 0.06
Adjusted Net Profit -64.40 -52.06 -20.02 -27.92 -40.24 -22.69
Adjustment below Net Profit -0.22 -0.06 -0.06 0.19 -0.15 -0.31
P & L Balance brought forward 86.29 133.43 141.49 161.43 197.83 220.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 31.20 86.29 133.43 141.49 161.43 197.83
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -2.08 -2.16 -0.37 -0.92 -2.49 -1.78
Earnings Per Share(Adj)-Unit Curr -2.08 -2.16 -0.37 -0.92 -2.29 -1.64
Book Value 51.11 36.66 38.77 39.14 32.74 28.66
Book Value(Adj)-Unit Curr 51.11 36.66 38.77 39.14 30.17 26.41

Shareholding Pattern

  • Promoter Group

    65.47%

  • Public Share Holding

    34.53%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 183,466,264 64.93 183,466,264 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,533,736 0.54 1,533,736 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 185,000,000 65.47 185,000,000 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,353,818 0.48 1,353,818 16
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 21,224 0.01 3,224 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,697,042 2.72 7,697,042 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,072,184 3.21 9,054,184 27
2] Non Institution
Bodies Corporate 12,500,336 4.42 12,498,336 383
Clearing Members 0 0.00 0 0
Directors of their Relatives 325,637 0.12 325,637 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,160,888 1.47 4,160,888 1,380
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,254,539 0.80 2,254,539 1,309
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 18,896,289 6.69 18,896,289 23
Individuals holding nominal share capital up to Rs. 1 lakh 50,041,924 17.71 49,883,418 63,513
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 308,816 0.11 308,816 3
Sub Total 88,490,502 31.32 88,329,996 66,614
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 282,562,686 100.00 282,384,180 66,647

Company Background

Suven Life Sciences LtdMiscellaneous

  • Suven Life Sciences Ltd
  • BSE Code : 4916.0
  • ISIN : INE495B01038

  • Incorporation Year

    1989

  • Registered Office

    #8-2-334 SDE Serene Chambers
    6 th Floor Road No 5 Avenue 7, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23541142/3311/3315

  • FAX

    91-40-23541152

  • Chairman

    Venkateswarlu Jasti

  • Managing Director

  • Company Secretary

    Sangeetha Laxmi Kandari

  • Auditor

    Karvy & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Suven Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Suven Life Scie. 377.60 21.03 7.11 -189.75 -5.52
Apollo Hospitals 8,784.00 9,698.00 9,326.20 80.40 17.52
Kovai Medical 6,095.70 1,613.88 1,585.64 26.02 22.01
Vimta Labs 653.70 416.28 407.29 36.66 23.21
One Global Serv 526.90 147.84 147.04 13.93 57.17
Shree Pacetronix 136.00 16.92 16.80 16.39 9.01
Sharma E I Hosp. 95.50 30.19 29.87 26.45 12.77
Fortis Malar 45.38 6.30 0.00 412.55 14.94
Chennai Meena 38.88 35.67 34.82 -70.69 0.00
CCME Global 32.42 3.67 0.00 -170.63 32.01
Transgene Biotek 2.77 1.04 0.26 -13.19 0.00